References
- Germing U, Kobbe G, Haas, R, Gattermann N. Myelodysplastic Syndromes: Diagnosis, Prognosis, and Treatment. Deutsches Arzteblatt International 2013;110(46):783-90.
- Sekeres MA. The epidemiology of myelodysplastic syndromes. Hematology Oncology Clinics of North America 2010;24(2):287-94. https://doi.org/10.1016/j.hoc.2010.02.011
- Neukirchen J, Schoonen WM, Strupp C, Gattermann N, Aul C, Haas R, et al. Incidence and prevalence of myelodysplastic syndromes: Data from the Dusseldorf MDS-registry. Leukemia Research 2011; 35(12):1591-6. https://doi.org/10.1016/j.leukres.2011.06.001
- Montalban-Bravo G, Gracia-Manero G. Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management. American Journal of Hematology 2018;93(1):129-47. https://doi.org/10.1002/ajh.24930
- Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood 2012;120(12):2454-65. https://doi.org/10.1182/blood-2012-03-420489
- Klepin HD. Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly. Clinics in Geriatric Medicine 2016;32(1):155-73. https://doi.org/10.1016/j.cger.2015.08.010
- Kim JD. A case of myelodysplastic syndrome. Journal of Internal Korean Medicine 1999;20(1) :274-9.
- Kim JY, Joung JY, Son CG, Cho JH. Well-Managed Myelodysplastic Syndrome Patients Treated with Traditional Korean Medicine; Report of Two Cases. Journal of Internal Korean Medicine 2016;37(3) :539-47.
- Bejar R, Stevenson KE, Caughey BA, Abdel-Wahab O, Steensma DP, Galili N, et al. Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes. Journal of Clinical Oncology 2012;30(27):3376-82. https://doi.org/10.1200/JCO.2011.40.7379
- Gangat N, Patnaik MM, Tefferi A. Myelodysplastic syndromes: Contemporary review and how we treat. American journal of hematology 2016;91(1) :76-89. https://doi.org/10.1002/ajh.24253
- Kim WH, Choi DY. Jangbubyeonzhengryonchi. Seoul: Seongbosa; 1985, p. 57-9, 63-5.
- Park SM, Kim YC, Lee JH, Woo HJ. Effects of Juakium-derivative on Hematopoietic Effects. Journal of Internal Korean Medicine 2002; 23(2):212-21.
- The faculty of Kyunghee university Korean medicine hospital. Kyungheehanbangcheobangjip. Seoul: Kyunghee university Korean medicine hospitial; 2007, p. 288.
- Shin JY. Explanation of Bangyakhappyun. Seoul: Sungbosa; 1988, p. 62.
- Schiffer CA, Bohlke K, Delaney M, Hume H, Maqdalinski AJ, McCullough JJ, et al. Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology 2018;36(3):283-99. https://doi.org/10.1200/JCO.2017.76.1734
- Cheson BD, Greenberg PL, Bennett JM, Lowenberg B, Wijermans PW, Nimer SD, et al. Clinical application and proposal for modeification of the International Working Group(IWG) response criteria in myelodysplasia. Blood 2006;108(2): 419-25. https://doi.org/10.1182/blood-2005-10-4149